BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21696864)

  • 1. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
    Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
    [No Abstract]   [Full Text] [Related]  

  • 2. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
    Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
    Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia.
    Kesari S; Akar S; Saad A; Drappatz J; Koralnik IJ; DeAngelo DJ
    J Clin Oncol; 2008 Aug; 26(22):3804-7. PubMed ID: 18669471
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
    Fanci R; Pini G; Bartolesi AM; Pecile P
    Rev Iberoam Micol; 2013 Jan; 30(1):51-3. PubMed ID: 22659590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.
    Kharfan-Dabaja MA; Ayala E; Greene J; Rojiani A; Murtagh FR; Anasetti C
    Bone Marrow Transplant; 2007 Jan; 39(2):101-7. PubMed ID: 17143300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation.
    Berger MD; Meisel A; Andres M; Schanz U; Schwarz U; Stussi G
    J Clin Oncol; 2014 Mar; 32(9):e33-4. PubMed ID: 24419131
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).
    Kaufman GP; Aksamit AJ; Klein CJ; Yi ES; Delone DR; Litzow MR
    Eur J Haematol; 2014 Jan; 92(1):83-7. PubMed ID: 24118404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zygomycosis in children: disseminated infection caused by Cunninghamella bertholletiae.
    González-Abad MJ; Alonso Sanz M
    Arch Bronconeumol; 2013 Jan; 49(1):35. PubMed ID: 23099279
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides.
    Gabriel IH; Olavarria E; Jones RR; Whittaker S; Chaidos A; Apperley JF
    Bone Marrow Transplant; 2007 Aug; 40(4):401-3. PubMed ID: 17589536
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir.
    Osorio S; de la Cámara R; Golbano N; Marti E; Fedele CG; Nieto S; Manzanares R; Fernández-Rañada JM
    Bone Marrow Transplant; 2002 Dec; 30(12):963-6. PubMed ID: 12476291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
    Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
    Bone Marrow Transplant; 1991; 7 Suppl 2():9-10. PubMed ID: 1878737
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantation.
    Lam W; Al-Shaibani Z; Kumar D; Viswabandya A; Thyagu S; Michelis FV; Kim DD; Lipton JH; Messner HA; Deotare U
    Antivir Ther; 2017; 22(8):721-725. PubMed ID: 28362268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
    Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for acute graft-versus-host disease.
    Khaled Y; Reddy P; Krijanovski O
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
    Vowels M; Stevens M; Tiedemann K; Brown R
    Transplant Proc; 1992 Feb; 24(1):184-5. PubMed ID: 1539237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.